Skip to content

Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty

Sonography-guided Pericapsular Nerve Group Block for Hip Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04480320
Acronym
QUASH
Enrollment
71
Registered
2020-07-21
Start date
2020-09-10
Completion date
2021-03-31
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Arthroplasty, Nerve Block

Keywords

Pericapsular Nerve Group, PENG, hip arthroplasty, Postoperative analgesia, quadriceps strength

Brief summary

In this study, the investigator will examine the efficacy of Pericapsular nerve group (PENG) block in hip arthroplasty as a post-operative pain management technique, study the analgesia, opioid-sparing effects and motor-blocking effects of the PENG block

Detailed description

PENG Block group (PG) will receive 0.5%Ropivacaine in 20 ml of saline. Sham Block group (SG) will receive 20 ml of saline Patient will be sedated with IV midazolam before nerve block. After peripheral nerve block ,general anesthesia will be conducted using sufentanyl, propofol and rocuronium for induction and propofol and sevoflurane for maintenance. Tests will be operated after procedure,and recorded up to 48 hours after surgery.

Interventions

PROCEDUREpericapsular nerve group block

Branches of both the FN and ON provide innervation to the anterior hip capsule. High and low branches of FN provided the majority of innervation to the lateral and superomedial hip capsule. The AON innervates the medial capsule.Both of the nerve close to the periosteum between the iliopubic eminence and AIIS ,by using ultrasound guided technique,these sites can be potential bony landmarks provid approch to the nerve group.

Sponsors

Guangzhou First People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for hip arthroplasty

Exclusion criteria

* allergy to local anesthetics * infection at the injection site * patients receiving opioids for chronic analgesic therapy * other lower limb neuropathies * inability to comprehend visual analog scale (VAS) * preexist cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Highest VAS score in recovery roombefore recovery room discharge(up to 2 hours after surgery end)Highest VAS score reported in recovery room,patient will be asked questions to measure the highest VAS score experienced in the recovery room before discharge. If the patient had a unexpected long stay at recovery room, the question will be asked at the time point 2 hours after surgery end

Secondary

MeasureTime frameDescription
highest VAS at periodday0 ,day1 ,day2highest VAS reported at follow up period
quadriceps strengthday0 , day1 ,day2Measure quadriceps strength peak value at different time point
total opioid consumptionup to 2 days after surgery
VAS at restday0 ,day1 ,day2VAS pain score while patient at rest
Fall incident happenedup to 2 days after surgeryRecord the fall incident happened,fall is defined as patinent accidently fall to the ground.
Nerve block rangeday0 , before discharge from PACU(up to 2 hours after surgery end)A cotton yarn with ethanol will be put on both the surgical and nonsurgical leg to evaluate the cold sensation lost after nerve block.Skin sensation lost will be tested at lateral thigh,medial thigh,front thigh and lateral claf
PONV rateday0 ,day1 ,day2postoperative nausea and vomit

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026